The Access to Medicine Index is a very important project. What gets measured, gets done.
New online: how pharma companies address access to cancer care
There is a growing cancer crisis in the developing world. In this new report, the Foundation analyses how pharmaceutical companies are responding. It finds 16 companies are taking action. Read more >>
News and Events
18 May 2017
15 May 2017
21 Apr 2017
06 Mar 2017
13 Dec 2016
New positions in Research, AMR, Communications
Interested in working toward the next Access to Medicine Index or our new AMR Benchmark? Or in joining the Foundation’s Communications team?
Access to medicine: a material issue for investors
Investors engage with the Foundation for insight into our analysis of the pharma sector, including into governance structures, R&D and pricing strategies.
The foundation on Twitter
“To improve access, we believe pharmaceutical companies need to focus on how
they deploy their products, and, as global citizens, collaborate on the development of strong health systems.”
Jayasree K. Iyer, Executive Director, Access to Medicine Foundation.
The Access to Medicine Foundation and its publications are funded by